Hi Stew, great to hear you have started treatment. Are you being supervised by your GP during treatment as these symptoms sound pretty severe?

So your specialist supports generics, wrote you a script to go through Greg J, but dId not recognise the drugs obtained through Buyers Club (Twinvir?).
The specialist now plans to support your treatment with branded Harvoni, which I can’t see as a bad outcome. I am sure someone will buy the generics off you.
Which state do you live in, by the way? I am curious why the specialist trusted Greg J so much but did not know about the FixHepC connection and the other generics.

.

I support Archer’s view that we should all put our basic treatment info as a signature in our profiles so we can comment on particular cases. Admittedly writing a signature is a bit unwieldy, but this will get you started: click on your name at the top of the page, then sign in again as demanded, enter signature details, then sign in again if prompted (I think it is twice?).
Now everyone will know your genotype, previous treatment etc without having to go back into old posts.

New Zealanders will need generics for a while yet, an estimated 50,000 of us.I imagine the A$37 deal for Aussies will stir interest over here.

About an avalanche of patients, I dunno, I had expected thousands to buy through Buyers Club back in October but it was a relative trickle of tens of people, although it has grown to thousands world wide now probably, still a fairly low response. There seem to be many people who know they have Hep C but won’t take action, even if it was free and in front of them. Many have been advised to wait. Members of this forum are the early movers.

My 2c worth on why the numbers seem nonsense: Cairns Dr Darren Russell told me on treatment w/o borders facebook site that he and GPs he has spoken to around the country are preparing to write scripts for Hep C patients which can be filled after March 1. He says there has been no official mention of triage and there must have been a significant Cap deal struck which throws the `risk’ of budget blowout back to big pharma – I am paraphrasing but it is the gist – soooo, if the $121m for 2015/16 is the spend limit, and whatever per dose price has been struck, the drug companies seem to have a lot of underwriting to do. Do they care about upsetting price deals made in the US and Europe? No, each market gets its own deal.
And what has Australia done to make it such a special case deserving of big pharma generosity? I think becoming a world centre for trusted generic sourcing has something to do with it. That and other promising drugs under development.

People at Hepatitis C Treatment w/o Borders are taking starkly different views on the announcement, from a spin exercise to cures for all as Sussan Ley says. Greg J is not buying it at all…